Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response

2012130 citationsJournal Article

Authors

Good health and well-being

Published in: Vaccine

Volume 30, Issue 39, pp. 5761-5769

Field-Weighted Citation Impact: 8.83